Additionally, IL-2 in combination with TGFβ as well as IL-34 alone have demonstrated the ability to expand both CD4+ Tregs and CD8+ Tregs, which may be leveraged to mitigate diseases such as lupus and GVHD194,195. The gene discussed is CD8A; the disease is systemic lupus erythematosus.